The overall goal of the research is the analysis of cellular-transforming genes in human neoplasms. We will focus on the nonvirus-related transforming genes that are activated in human B-lymphocyte neoplasms and detected by transfection of NIH 3T3 cells. These genes will be characterized by molecular cloning and nucleotide sequencing in order to identify their gene products and to determine the molecular alterations responsible for activation of their transforming potential in neoplastic cells. Antisera against predicted gene products will be used for characterization of these transforming proteins. The role of these transforming genes in lymphomagenesis will be investigated by transfection of human B lymphocytes. (X)
| Wolfes, H; Kogawa, K; Millette, C F et al. (1989) Specific expression of nuclear proto-oncogenes before entry into meiotic prophase of spermatogenesis. Science 245:740-3 |
| O'Keefe, S J; Wolfes, H; Kiessling, A A et al. (1989) Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg. Proc Natl Acad Sci U S A 86:7038-42 |
| Stanton Jr, V P; Nichols, D W; Laudano, A P et al. (1989) Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Mol Cell Biol 9:639-47 |
| Goldman, D S; Kiessling, A A; Cooper, G M (1988) Post-transcriptional processing suggests that c-mos functions as a maternal message in mouse eggs. Oncogene 3:159-62 |
| Takahashi, M; Cooper, G M (1987) ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7:1378-85 |
| Diamond, A; Devine, J M; Lane, M A et al. (1985) The isolation and characterization of the Blym-1 transforming gene. Basic Life Sci 33:141-52 |
